| Followers | 196 |
| Posts | 13482 |
| Boards Moderated | 0 |
| Alias Born | 06/20/2022 |
Monday, May 22, 2023 10:48:31 AM
MBOT: Me neither, Dude. (Cheap ANIMAL study; long way from anything HUMANS.)
HOWEVER!!! Since they gots lots of cute ROBOTICS stuff, well, maybe THAT's what's 'trending' on THIS particular day.
HOWEVER!!! Since they gots lots of cute ROBOTICS stuff, well, maybe THAT's what's 'trending' on THIS particular day.
Recent MBOT News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/02/2026 12:30:26 PM
- Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System • GlobeNewswire Inc. • 06/02/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/26/2026 12:30:22 PM
- Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System • GlobeNewswire Inc. • 05/26/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 04:03:18 PM
- Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu • GlobeNewswire Inc. • 05/15/2026 01:56:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 12:30:25 PM
- Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026 • GlobeNewswire Inc. • 05/14/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 09:16:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 12:30:15 PM
- Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites • GlobeNewswire Inc. • 05/05/2026 12:30:00 PM
- Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA) • GlobeNewswire Inc. • 04/30/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 12:30:29 PM
- Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY® • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/14/2026 06:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 12:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 12:30:16 PM
- Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting • GlobeNewswire Inc. • 04/13/2026 12:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 09:10:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 09:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:30:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:30:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:30:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:30:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:30:10 PM
